连接组织疾病作为心力衰竭的挑战:三个病例报告
Ke Liu1, Xuejiao Li1, Dan Li2
1Emergency Department of the Second Affiliated Hospital of ChongQing Medical University, Chongqing 400010, China.
Medicine
|January 19, 2024
概括
连接组织疾病 (CTD) 可以导致心力衰竭 (HF),这是一个严重的并发症. 在CTD患者中早期识别和治疗HF可以改善结果和生活质量.
科学领域:
- 类风湿病学 类风湿病学
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 连接组织疾病 (CTD) 是一种慢性,全身性自身免疫性疾病,其特征是免疫失调.
- CTD经常通过不同的病理生理路径影响心脏结构,往往导致亚临床心脏损伤.
- 心力衰竭 (HF) 是CTD患者的一种已知且显著的并发症.
研究的目的:
- 突出CTD患者心血管疾病风险增加,包括HF.
- 强调在CTD患者群体中识别胸痛和呼吸短促等HF症状的重要性.
- 强调早期诊断和适当管理HF的必要性,以改善患者的预后.
主要方法:
- 审查与CTD相关的临床表现和并发症.
- 分析CTD与心脏功能障碍和HF联系的病理生理机制.
- 检查心脏症状的CTD患者的治疗策略.
主要成果:
- 患有CTD的患者面临心血管疾病的风险增加,并且可能出现胸痛和呼吸障碍等症状.
- 在CTD患者中,HF可能源于心肌损伤,膜问题或冠状动脉缺血.
- 包括皮质类固醇和抗凝药在内的治疗干预措施显示,胸痛和呼吸短促等症状有所改善.
结论:
- 心力衰竭是CTD的常见和严重并发症,预后不佳.
- 在CTD患者中,迅速识别HF症状 (胸痛,呼吸短促) 是至关重要的.
- 早期识别和治疗HF可以减轻疾病的进展,改善预后,并改善CTD患者的生活质量.
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:11Introduction to Connective Tissues
9.6K
Connective tissues are one of the four main tissue types in humans that are extensively present in the body. They are characterized by cells embedded in an extracellular matrix (ECM) composed of a ground substance and three main types of protein fibers— collagen, elastic, and reticular fibers. The ground substance of connective tissues can range from a watery and jelly-like consistency to mineralized and hard. The wide variety of cells in the connective tissues include fibroblasts,...
9.6K
01:22Heart Failure Drugs: Diuretics
384
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
384
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
432
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432
01:26Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591